Cargando…

Early phase and adaptive design clinical trials in rheumatoid arthritis: a systematic review of early phase trials

OBJECTIVE: Adaptive designs can enable highly sophisticated and efficient early phase trials, but the clinical inference from these trials is surrounded by complexity, and currently there is a paucity but steadily increasing amount of use of these designs in all fields of medicine. We aim to review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pickles, Tim, Christensen, Robin, Tam, Lai-Shan, Simon, Lee S, Choy, Ernest H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649924/ https://www.ncbi.nlm.nih.gov/pubmed/31431982 http://dx.doi.org/10.1093/rap/rky045

Ejemplares similares

TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis
por: Cole, M., et al.
Publicado: (2021)

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial
por: Siebert, Stefan, et al.
Publicado: (2020)

Caspase-1 is active since the early phase of rheumatoid arthritis
por: Cascão, R, et al.
Publicado: (2010)

Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines
por: Pickles, Tim, et al.
Publicado: (2022)

Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
por: Avci, Ali Berkant, et al.
Publicado: (2021)

CD28(−) Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status
por: Thompson, Charlotte, et al.
Publicado: (2020)

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
por: Winthrop, Kevin L., et al.
Publicado: (2017)

Fatigue in rheumatoid arthritis
por: Choy, Ernest H, et al.
Publicado: (2019)

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis
por: Mysler, Eduardo, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials
por: Choy, Ernest H, et al.
Publicado: (2013)

Phase II Trials in Drug Development and Adaptive Trial Design
por: Van Norman, Gail A.
Publicado: (2019)

Retrocalcaneal Bursitis Precedes or Accompanies Achilles Tendon Enthesitis in the Early Phase of Rheumatoid Arthritis
por: Suzuki, Takeshi, et al.
Publicado: (2018)

Therapeutics for Dengue: Recommendations for Design and Conduct of Early-Phase Clinical Trials
por: Simmons, Cameron P., et al.
Publicado: (2012)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Early phase clinical trials in oncology: realising the potential of seamless designs
por: Jaki, Thomas, et al.
Publicado: (2023)

Genetic Variants Associated with Methotrexate Efficacy and Toxicity in Early Rheumatoid Arthritis: Results from the Treatment of Early Aggressive Rheumatoid Arthritis Trial
por: Aslibekyan, Stella, et al.
Publicado: (2013)

Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept
por: Ahmad, Harris A., et al.
Publicado: (2022)

Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013)

Minimax and admissible adaptive two-stage designs in phase II clinical trials
por: Shan, Guogen, et al.
Publicado: (2016)

Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis
por: Nagpal, Anjali, et al.
Publicado: (2017)

Fatigue in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Network
por: Ifesemen, Onosi Sylvia, et al.
Publicado: (2021)

Exposure–Response Analyses of Upadacitinib Efficacy in Phase II Trials in Rheumatoid Arthritis and Basis for Phase III Dose Selection
por: Mohamed, Mohamed‐Eslam F., et al.
Publicado: (2019)

Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial
por: Svensson, Annemarie Lyng, et al.
Publicado: (2016)

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
por: Hetland, Merete Lund, et al.
Publicado: (2020)

Practical considerations for the implementation of adaptive designs for oncology Phase I dose-finding trials
por: Wei, Lai, et al.
Publicado: (2019)

The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
por: Cho, Nicholas S., et al.
Publicado: (2023)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
por: Smolen, Josef S, et al.
Publicado: (2016)

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
por: Burmester, Gerd R, et al.
Publicado: (2016)

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
por: Choy, Ernest, et al.
Publicado: (2018)

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
por: Choy, Ernest, et al.
Publicado: (2018)

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
por: Antoniou, Miranta, et al.
Publicado: (2016)

Pathogenesis of rheumatoid arthritis: how early is early?
por: Firestein, Gary S
Publicado: (2005)

Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
por: Choy, Ernest H S, et al.
Publicado: (2018)

Efficacy and Safety of 22-Oxa-Calcitriol in Patients with Rheumatoid Arthritis: A Phase II Trial
por: Li, Chaohong, et al.
Publicado: (2018)

An overview of the BOIN design and its current extensions for novel early-phase oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2022)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Charles-Schoeman, Christina, et al.
Publicado: (2023)

Early-Phase Interventional Trials in Oral Cancer Prevention
por: McCarthy, Caroline, et al.
Publicado: (2021)

Update of early phase clinical trials in cancer immunotherapy
por: Lee, Dae Ho
Publicado: (2021)

Early phase clinical trials in India: Need & scope
por: Kshirsagar, Nilima Arun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_intpbha63o3dt7uum3k38ofiq5